The release of the unredacted text of the HHS recommendation has spurred cannabis equity prices upward. The MSOS ETF (NYSE: MSOS) has risen approximately 27% over the last month. But has the pricing strength been accompanied by greater absolute and relative trading volumes?
The Viridian Credit Tracker model is a valuable tool for investors and companies alike to gauge the credit quality of cannabis companies. The model utilizes 11 market-based and financial statement-based variables to measure four critical attributes of credit quality: Liquidity, Leverage, Profitability, and Size.
The MSOS ETF is now up 41.4% from the August 30, 2023, HHS rescheduling announcement, but it has fallen significantly from its peak gain of 85.0% in mid-September. The Viridian Chart of the Week looks at the potential upside and downside of the top 15 MSOs concerning a DEA announcement on rescheduling.
The Viridian Chart of the Week shows analyst estimates for MSO revenue for the third quarter of 2023 relative to the second quarter of 2023 and the third quarter of 2022. The green bars depict estimated sequential quarter growth for Q3:23, while the orange bars show year-over-year growth.